| __timestamp | Amphastar Pharmaceuticals, Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 40373000 | 38783000000 |
| Thursday, January 1, 2015 | 46974000 | 42585000000 |
| Friday, January 1, 2016 | 47298000 | 45702000000 |
| Sunday, January 1, 2017 | 50918000 | 46372000000 |
| Monday, January 1, 2018 | 58044000 | 46910000000 |
| Tuesday, January 1, 2019 | 63109000 | 48890000000 |
| Wednesday, January 1, 2020 | 65157000 | 50129000000 |
| Friday, January 1, 2021 | 68920000 | 54559000000 |
| Saturday, January 1, 2022 | 66592000 | 62081000000 |
| Sunday, January 1, 2023 | 80393000 | 105931000000 |
| Monday, January 1, 2024 | 77201000000 |
Unleashing insights
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Dr. Reddy's Laboratories Limited and Amphastar Pharmaceuticals, Inc. have showcased contrasting trends in their SG&A efficiency. From 2014 to 2023, Dr. Reddy's Laboratories consistently reported higher SG&A expenses, peaking at approximately $106 billion in 2023, a staggering 173% increase from 2014. In contrast, Amphastar Pharmaceuticals saw a more modest rise, with expenses growing by about 99% over the same period, reaching $80 million in 2023. This divergence highlights the different strategic approaches of these companies in managing operational costs. Notably, the data for 2024 is incomplete, indicating a potential shift or anomaly in reporting. As the pharmaceutical landscape evolves, these insights offer a glimpse into the financial strategies shaping the industry's future.
AbbVie Inc. or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: GSK plc vs Dr. Reddy's Laboratories Limited Trends and Insights
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Opthea Limited
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Halozyme Therapeutics, Inc.
Dr. Reddy's Laboratories Limited or Alkermes plc: Who Manages SG&A Costs Better?
Dr. Reddy's Laboratories Limited or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Dr. Reddy's Laboratories Limited vs BioCryst Pharmaceuticals, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.
Protagonist Therapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Amphastar Pharmaceuticals, Inc. and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Amphastar Pharmaceuticals, Inc. vs Novavax, Inc.